About Prof Jo Douglass
Jo Douglass is a specialist in Allergy and Respiratory Medicine. She sees patients in clinics at the Royal Melbourne Hospital and privately at Melbourne Private Hospital.
Jo trained in medicine at ...
Special interests
Qualifications
- BMedSc (hons) Monash University 1983
- MBBS (hons) Monash University 1984
- Fellowship of the Royal Australian College of Physicians 1992
- Doctor of Medicine Monash Univeristy 2000
Awards and Publications
- Barnes S, Kotecha S, Douglass JA, Paul E, Hore-Lacey F, Stirling R, Snell GI, Westall GP. Evolving Practice: X-Linked Agammaglobulinemia and Lung Transplantation. Am J Transplant. 2015 Mar 3. doi: 10.1111/ajt.13084. PMID: 25736826
- Voskamp AL, Gillman A, Symons K, Sandrini A, Rolland JM, O'Hehir RE, Douglass JA. Clinical Efficacy and Immunological Effects of Omalizumab in Allergic Bronchopulmonary Aspergillosis. J Allergy Clin Immunol Pract. 2015 Jan 29. pii: S2213-2198(14)00643-6. doi: 10.1016/j.jaip.2014.12.008. PMID: 25640470
- Jo A Douglass, Nur-Shirin Harun. Severe asthma: new frontiers of treatment January 2015 Medicine Today 2015; 16(1): 27-33
4. Crane MA, Jenkins CR, Goeman DP, Douglass JA. Inhaler device technique can be improved in older adults through tailored education: findings from a randomised controlled trial. NPJ Prim Care Respir Med. 2014;24:14034. doi: 10.1038/npjpcrm.2014.34. PMID:
5. Holgate ST, Douglass JA (eds) Fast Facts: Asthma (4th Ed) Health Press Ltd , Abingdon, Oxford OX14 3LN, UK. 2013
6. Chua JC, Douglass JA, Gillman A, O'Hehir RE, Meeusen EN (2012) Galectin-10, a Potential Biomarker of Eosinophilic Airway Inflammation. PLoS ONE 7(8): e42549. doi:10.1371/journal.pone.0042549
7. Goeman DP, Abramson MJ, McCarthy EA, Zubrinich CM, Douglass JA. Asthma mortality in Australia in the 21st century: a case series analysis. BMJ Open. 2013 May 28;3(5). doi:pii: e002539. 10.1136/bmjopen-2012-002539PMID: 25188403
8. Chen Y, Stirling R, Hore-Lacy F, Thompson B, Douglass JA. Longitudinal decline in lung function in patients with primary immunoglobulin deficiencies. J Allergy Clin Immunol 2011. 127: 1414-7
9. Douglass JA, Carroll K, Voskamp A, Bourke P, Wei A, O’Hehir RE. Omalizumab is effective in treating systemic mastocytosis in a non-atopic patient. Allergy 2010; 65: 926-7. DOI: 10. 1111/ J.1398-99 95.2009.02259